vs
Side-by-side financial comparison of Prelude Therapeutics Inc (PRLD) and X3 Holdings Co., Ltd. (XTKG). Click either name above to swap in a different company.
Prelude Therapeutics Inc is the larger business by last-quarter revenue ($6.5M vs $5.0M, roughly 1.3× X3 Holdings Co., Ltd.).
PRLD vs XTKG — Head-to-Head
Income Statement — Q3 FY2025 vs Q2 FY2025
| Metric | | |
|---|---|---|
| Revenue | $6.5M | $5.0M |
| Net Profit | $-19.7M | — |
| Gross Margin | — | — |
| Operating Margin | -314.1% | — |
| Net Margin | -303.5% | — |
| Revenue YoY | 116.7% | — |
| Net Profit YoY | 38.9% | — |
| EPS (diluted) | $-0.26 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | $6.5M | — | ||
| Q2 25 | — | $5.0M | ||
| Q3 24 | $3.0M | — | ||
| Q2 24 | — | $6.6M |
| Q3 25 | $-19.7M | — | ||
| Q2 25 | — | — | ||
| Q3 24 | $-32.3M | — | ||
| Q2 24 | — | $-57.6M |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 28.0% |
| Q3 25 | -314.1% | — | ||
| Q2 25 | — | — | ||
| Q3 24 | -1145.9% | — | ||
| Q2 24 | — | -219.1% |
| Q3 25 | -303.5% | — | ||
| Q2 25 | — | — | ||
| Q3 24 | -1075.7% | — | ||
| Q2 24 | — | -874.1% |
| Q3 25 | $-0.26 | — | ||
| Q2 25 | — | — | ||
| Q3 24 | $-0.43 | — | ||
| Q2 24 | — | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $55.0M | $2.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $58.5M | $42.6M |
| Total Assets | $94.8M | $71.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $55.0M | — | ||
| Q2 25 | — | $2.6M | ||
| Q3 24 | $153.6M | — | ||
| Q2 24 | — | $1.5M |
| Q3 25 | $58.5M | — | ||
| Q2 25 | — | $42.6M | ||
| Q3 24 | $156.4M | — | ||
| Q2 24 | — | $125.5M |
| Q3 25 | $94.8M | — | ||
| Q2 25 | — | $71.7M | ||
| Q3 24 | $197.2M | — | ||
| Q2 24 | — | $171.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-19.1M | $-1.1M |
| Free Cash FlowOCF − Capex | — | $-1.7M |
| FCF MarginFCF / Revenue | — | -34.1% |
| Capex IntensityCapex / Revenue | 0.0% | 12.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $-19.1M | — | ||
| Q2 25 | — | $-1.1M | ||
| Q3 24 | $-27.3M | — | ||
| Q2 24 | — | $-7.0M |
| Q3 25 | — | — | ||
| Q2 25 | — | $-1.7M | ||
| Q3 24 | $-27.4M | — | ||
| Q2 24 | — | $-7.0M |
| Q3 25 | — | — | ||
| Q2 25 | — | -34.1% | ||
| Q3 24 | -912.0% | — | ||
| Q2 24 | — | -106.9% |
| Q3 25 | 0.0% | — | ||
| Q2 25 | — | 12.1% | ||
| Q3 24 | 2.1% | — | ||
| Q2 24 | — | 0.3% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PRLD
Segment breakdown not available.
XTKG
| Consulting and technical support services | $2.4M | 48% |
| Other | $1.5M | 30% |
| Application development services | $884.5K | 18% |
| Subscription services | $215.4K | 4% |
